TY - JOUR
T1 - Altered distribution of debrisoquine oxidation phenotypes in patients with systemic lupus erythematosus
AU - Baer, Alan N.
AU - McAllister, C. B.
AU - Wilkinson, Grant R.
AU - Woosley, Raymond L.
AU - Pincus, Theodore
PY - 1986/7
Y1 - 1986/7
N2 - Oxidative metabolism in patients with systemic lupus erythematosus (SLE) was studied using the antihypertensive drug, debrisoquine. The metabolism of this drug to its principal metabolite, 4‐hydroxy‐debrisoquine, is catalyzed by a discrete isozyme of cytochrome P‐450. The extent of this reaction exhibits genetic polymorphism, with 2 phenotypes, “poor metabolizers” and “extensive metabolizers,” discernible in the normal population. We observed the poor metabolizer debrisoquine phenotype in 9 of 42 patients with idiopathic SLE (21%), in contrast with 12 of 147 healthy volunteers (8%), which is a significant difference in frequency (P < 0.04). These data provide further evidence for altered oxidative metabolism in SLE and support the concept that genetic differences in oxidative metabolism of endogenous compounds, such as sex steroid hormones, or of xenobiotics might influence susceptibility to SLE.
AB - Oxidative metabolism in patients with systemic lupus erythematosus (SLE) was studied using the antihypertensive drug, debrisoquine. The metabolism of this drug to its principal metabolite, 4‐hydroxy‐debrisoquine, is catalyzed by a discrete isozyme of cytochrome P‐450. The extent of this reaction exhibits genetic polymorphism, with 2 phenotypes, “poor metabolizers” and “extensive metabolizers,” discernible in the normal population. We observed the poor metabolizer debrisoquine phenotype in 9 of 42 patients with idiopathic SLE (21%), in contrast with 12 of 147 healthy volunteers (8%), which is a significant difference in frequency (P < 0.04). These data provide further evidence for altered oxidative metabolism in SLE and support the concept that genetic differences in oxidative metabolism of endogenous compounds, such as sex steroid hormones, or of xenobiotics might influence susceptibility to SLE.
UR - http://www.scopus.com/inward/record.url?scp=0022532646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022532646&partnerID=8YFLogxK
U2 - 10.1002/art.1780290705
DO - 10.1002/art.1780290705
M3 - Article
C2 - 3741500
AN - SCOPUS:0022532646
SN - 0004-3591
VL - 29
SP - 843
EP - 850
JO - Arthritis & Rheumatism
JF - Arthritis & Rheumatism
IS - 7
ER -